Vimarsana
Biggest News Aggregation in the World

Pharma Price News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Price. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Price Today - Breaking & Trending Today

PLx Pharma (NASDAQ:PLXP) Stock Passes Above Fifty Day Moving Average of $0.00 - Vimarsana News

PLx Pharma (NASDAQ:PLXP) Stock Passes Above Fifty Day Moving Average of $0.00

PLx Pharma Inc. (NASDAQ:PLXP – Get Free Report)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. PLx Pharma shares last traded at $0.00, with a volume of 3,000 shares. PLx Pharma Price Performance […]

ABVC BioPharma (OTCMKTS:ABVC) Trading 10% Higher - Vimarsana News

ABVC BioPharma (OTCMKTS:ABVC) Trading 10% Higher

Shares of ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Free Report) traded up 10% during mid-day trading on Tuesday . The company traded as high as $0.44 and last traded at $0.42. 410,710 shares were traded during trading, an increase of 0% from the average session volume of 409,231 shares. The stock had previously closed at […]

Source: wkrb13.com
CTI BioPharma (NASDAQ:CTIC) Now Covered by StockNews.com - Vimarsana News

CTI BioPharma (NASDAQ:CTIC) Now Covered by StockNews.com

StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts also recently issued research reports about the stock. TD Cowen reduced their target price on shares of CTI BioPharma from $10.00 to $8.00 […]

Source: wkrb13.com
StockNews.com Initiates Coverage on CTI BioPharma (NASDAQ:CTIC) - Vimarsana News

StockNews.com Initiates Coverage on CTI BioPharma (NASDAQ:CTIC)

Research analysts at StockNews.com began coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Other research analysts have also issued reports about the company. TD Cowen lowered their price objective on CTI BioPharma from $10.00 […]

StockNews.com Begins Coverage on CTI BioPharma (NASDAQ:CTIC) - Vimarsana News

StockNews.com Begins Coverage on CTI BioPharma (NASDAQ:CTIC)

StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research report report published on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. CTIC has been the topic of a number of other research reports. Stifel Nicolaus cut CTI BioPharma from a buy rating to a hold […]